Rm4a

Uses your system voice; voice and rate in settings.

Snapshot

≈ 3 min read

Names in other languages

No names in other languages are held for this entry yet.

Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.

Rm4a is a toxin found in the venom of the Australian green-head ant (Rhytidoponera metallica), which is used for self-defense. Upon administration, Rm4a causes immediate pain by disrupting the normal function of the voltage-gated sodium channels in mammalian peripheral sensory neurons, differing from other ion channel toxins in the ant venom.

Rm4a is a toxin found in the venom of the Australian green-head ant (Rhytidoponera metallica), which is used for self-defense. Upon administration, Rm4a causes immediate pain by disrupting the normal function of the voltage-gated sodium channels in mammalian peripheral sensory neurons, differing from other ion channel toxins in the ant venom.

Structure

The ectatoxin Rm4a is a relatively small peptide that consists of 26 amino acids: FPPLLLLAGLFSLPALQHYIETKWIN-NH2. It has a molecular mass under 6 kDa, consistent with the majority of R. metallica peptide venom components. Unlike many animal venom peptides, Rm4a does not have cysteine residues. Its lysine-rich structure provides positive charge and amphipathic properties, enabling the peptide to interact with the lipid membrane and ion channel of mammalians. The C-terminal region of Rm4a is amidated, which neutralizes the terminal carbonyl group and increases chemical stability of its structure. Together, Rm4a's chemical structure provides support for its selective modulation of vertebrate voltage-gated sodium channels.

Homology and family

The venom of R. metallica consists predominantly of peptides derived from the aculeatoxin gene superfamily. As a mature peptide, Rm4a shares high sequence similarity (63-71%) with pain-inducing peptides from other ant species. Within R. metallica venom, Rm4a shares biophysical features (lysine and hydrophobic-rich sequences) with other aculeatoxins that facilitate amphipathic helix formation. Rm4a clusters within vertebrate-selective sodium channel modulators with other homologous toxins (e.g., Ta3a, Pm1a, and Mri1a) from other ant species. These peptides evolved under selection pressure for defense against vertebrate predators. Rm4a targets mammalian voltage-gated sodium (Na V ) channels; including Na V 1.6, Na V 1.7, Na V 1.8, and Na V 1.9. and it functions primarily as a vertebrate-selective defensive toxin that causes sustained nociception in mammals. The affinity of Rm4a for different voltage-gated sodium channels varies. Rm4a exhibits the highest affinity and potency in human NaV (hNa V ) 1.6 (EC50 = 196 ± 23 nM), and lower affinity in hNaV1.7 (EC50 = 1.9 ± 0.4 μM) and hNaV1.8 (EC50 = 8.4 ± 1.0 μM). Although Rm4a modulation of hNa V 1.6 has a greater amplitude than hNa V 1.7, the effects of Rm4a on both currents are similar at the same toxin concentration.

Text derived from https://en.wikipedia.org/w/index.php?oldid=1374811307 under CC BY-SA 4.0; modifications have been made.

Sources cited in this revision

5 named source(s) extracted from the cited revision. A source with no author is shown by its publication; nothing is invented.